WallStreetZenWallStreetZen

NASDAQ: SYNH
Syneos Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SYNH

Based on 8 analysts offering 12 month price targets for Syneos Health Inc.
Min Forecast
$28.00-17.82%
Avg Forecast
$48.75+43.09%
Max Forecast
$77.00+126.01%

Should I buy or sell SYNH stock?

Based on 10 analysts offering ratings for Syneos Health Inc.
Hold
Strong Buy
1 analysts 10%
Buy
1 analysts 10%
Hold
6 analysts 60%
Sell
0 analysts 0%
Strong Sell
2 analysts 20%

Be the first to know when Wall Street analysts revise their SYNH stock forecasts and price targets.

SYNH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Barclays
Bottom 2%
2
Strong SellMaintains$45.00+32.08%2023-03-01
Mizuho
Top 16%
85
HoldReiterates$38.00+11.54%2023-02-17
Baird
Bottom 16%
16
BuyMaintains$51.00+49.69%2023-02-17
JP Morgan
Bottom 21%
21
Strong SellDowngrades$28.00-17.82%2023-02-13
Citigroup
Top 5%
96
HoldMaintains$30.00-11.95%2022-11-07
JP Morgan
Top 20%
81
HoldDowngrades$53.00+55.56%2022-10-18
Deutsche Bank
Bottom 12%
12
Strong BuyMaintains$77.00+126.01%2022-10-12
Guggenheim
Top 7%
94
HoldDowngradesN/AN/A2022-09-14
UBS
Bottom 16%
16
HoldInitiates Coverage On$68.00+99.59%2022-09-07
Jefferies
Top 4%
97
HoldDowngradesN/AN/A2022-04-25

1 of 1

Forecast return on equity

Is SYNH forecast to generate an efficient return?
Company
18.61%
Industry
54.11%
Market
52.49%
SYNH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SYNH forecast to generate an efficient return on assets?
Company
7.93%
Industry
14.49%
SYNH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SYNH earnings per share forecast

What is SYNH's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$4.82+86.1%
Avg 2 year Forecast
$5.55+114.29%
Avg 3 year Forecast
$6.30+143.24%
SYNH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SYNH revenue forecast

What is SYNH's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$5.8B+7.93%
Avg 2 year Forecast
$6.2B+15.85%
Avg 3 year Forecast
$6.7B+23.6%
SYNH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SYNH earnings growth forecast

How is SYNH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
46.49%
Industry
33.26%
Market
26.78%
SYNH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SYNH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SYNH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SYNH revenue growth forecast

How is SYNH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
7.61%
Industry
10.67%
Market
9.35%
SYNH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SYNH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SYNH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
SYNH$34.07$48.75+43.09%Hold
NEOG$18.13$17.00-6.23%Buy
GH$25.95$55.92+115.50%Strong Buy
OLK$21.80$23.60+8.26%Buy
NEO$18.47$20.11+8.88%Strong Buy
View Top Diagnostic & Research Stocks

Syneos Health Stock Forecast FAQ

Is Syneos Health Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 10 Wall Street analysts covering (NASDAQ: SYNH) stock is to Hold SYNH stock.

Out of 10 analysts, 1 (10%) are recommending SYNH as a Strong Buy, 1 (10%) are recommending SYNH as a Buy, 6 (60%) are recommending SYNH as a Hold, 0 (0%) are recommending SYNH as a Sell, and 2 (20%) are recommending SYNH as a Strong Sell.

If you're new to stock investing, here's how to buy Syneos Health stock.

What is SYNH's earnings growth forecast for 2023-2025?

(NASDAQ: SYNH) Syneos Health's forecast annual earnings growth rate of 46.49% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 33.26%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 26.78%.

Syneos Health's earnings in 2023 is $266,497,000.On average, 4 Wall Street analysts forecast SYNH's earnings for 2023 to be $497,623,379, with the lowest SYNH earnings forecast at $484,202,002, and the highest SYNH earnings forecast at $511,044,757. On average, 1 Wall Street analyst forecast SYNH's earnings for 2024 to be $572,989,576, with the lowest SYNH earnings forecast at $572,989,576, and the highest SYNH earnings forecast at $572,989,576.

In 2025, SYNH is forecast to generate $650,420,600 in earnings, with the lowest earnings forecast at $650,420,600 and the highest earnings forecast at $650,420,600.

What is SYNH's revenue growth forecast for 2023-2025?

(NASDAQ: SYNH) Syneos Health's forecast annual revenue growth rate of 7.61% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 10.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.35%.

Syneos Health's revenue in 2023 is $5,393,082,000.On average, 4 Wall Street analysts forecast SYNH's revenue for 2023 to be $600,946,098,496, with the lowest SYNH revenue forecast at $591,200,320,122, and the highest SYNH revenue forecast at $606,298,337,340. On average, 3 Wall Street analysts forecast SYNH's revenue for 2024 to be $645,019,733,973, with the lowest SYNH revenue forecast at $643,190,916,433, and the highest SYNH revenue forecast at $647,528,808,866.

In 2025, SYNH is forecast to generate $688,214,269,227 in revenue, with the lowest revenue forecast at $688,214,269,227 and the highest revenue forecast at $688,214,269,227.

What is SYNH's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: SYNH) forecast ROA is 7.93%, which is lower than the forecast US Diagnostics & Research industry average of 14.49%.

What is SYNH's Price Target?

According to 8 Wall Street analysts that have issued a 1 year SYNH price target, the average SYNH price target is $48.75, with the highest SYNH stock price forecast at $77.00 and the lowest SYNH stock price forecast at $28.00.

On average, Wall Street analysts predict that Syneos Health's share price could reach $48.75 by Mar 1, 2024. The average Syneos Health stock price prediction forecasts a potential upside of 43.09% from the current SYNH share price of $34.07.

What is SYNH's Earnings Per Share (EPS) forecast for 2023-2025?

(NASDAQ: SYNH) Syneos Health's current Earnings Per Share (EPS) is $2.59. On average, analysts forecast that SYNH's EPS will be $4.82 for 2023, with the lowest EPS forecast at $4.69, and the highest EPS forecast at $4.95. On average, analysts forecast that SYNH's EPS will be $5.55 for 2024, with the lowest EPS forecast at $5.55, and the highest EPS forecast at $5.55. In 2025, SYNH's EPS is forecast to hit $6.30 (min: $6.30, max: $6.30).

What is SYNH's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: SYNH) forecast ROE is 18.61%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.